Ignite Creation Date:
2025-12-24 @ 12:09 PM
Ignite Modification Date:
2026-01-06 @ 4:51 AM
Study NCT ID:
NCT02563561
Status:
TERMINATED
Last Update Posted:
2021-10-27
First Post:
2015-09-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Intravesical Apaziquone as a Surgical Adjuvant in Participant Undergoing Transurethral Resection Bladder Tumor (TURBT)
Sponsor:
Spectrum Pharmaceuticals, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-09
Start Date Type:
ACTUAL
Primary Completion Date:
2017-03-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-10
Completion Date Type:
ACTUAL
First Submit Date:
2015-09-21
First Submit QC Date:
None
Study First Post Date:
2015-09-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-08-30
Results First Submit QC Date:
None
Results First Post Date:
2021-09-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-08
Last Update Post Date:
2021-10-27
Last Update Post Date Type:
ACTUAL